» Articles » PMID: 22759353

Using Pathology-specific Laboratory Profiles in Clinical Pathology to Reduce Inappropriate Test Requesting: Two Completed Audit Cycles

Abstract

Background: Systematic reviews have shown that, although well prepared, the Consensus Guidelines have failed to change clinical practice. In the healthcare district of Castelnovo né Monti (Reggio Emilia, Italy), it became necessary for the GPs and Clinical Pathologists to work together to jointly define laboratory profiles.

Methods: Observational study with two cycles of retrospective audit on test request forms, in a primary care setting. Objectives of the study were to develop pathology-specific laboratory profiles and to increase the number of provisional diagnoses on laboratory test request forms. A Multiprofessional Multidisciplinary Inter-hospital Work Team developed pathology-specific laboratory profiles for more effective test requesting. After 8 training sessions that used a combined strategy with multifaceted interventions, the 23 General Practitioners (GPs) in the trial district (Castelnovo nè Monti) tested the profiles; the 21 GPs in the Puianello district were the control group; all GPs in both districts participated in the trial. All laboratory tests for both healthcare districts are performed at the Laboratory located in the trial district. A baseline and a 1-year audit were performed in both districts on the GPs' request forms.

Results: Seven pathology-specific laboratory profiles for outpatients were developed. In the year after the first audit cycle: 1) the number of tests requested in the trial district was distinctly lower than that in the previous year, with a decrease of about 5% (p < 0.001); 2) the provisional diagnosis on the request forms was 52.8% in the trial district and 42% in the control district (P < 0.001); 3) the decrease of the number of tests on each request form was much more marked in the trial district (8.73 vs. 10.77; p < 0.001).

Conclusions: The first audit cycle showed a significant decrease in the number of tests ordered only in the trial district. The combined strategy used in this study improved the prescriptive compliance of most of the GPs involved. The presence of the clinical pathologist is seen as an added value.

Citing Articles

Impact of novel software on laboratory expenditure at an academic hospital in South Africa.

Mayekiso Z, Oladimeji K, Estrada G, Hongoro C, Apalata T Afr J Lab Med. 2023; 12(1):2159.

PMID: 38058853 PMC: 10696537. DOI: 10.4102/ajlm.v12i1.2159.


Rethinking Blood Testing in Pediatric Cancer Patients: A Quality Improvement Approach.

Grant A, Wright F, Chapman L, Cook E, Byrne R, OBrien T Pediatr Qual Saf. 2022; 7(3):e552.

PMID: 35720866 PMC: 9197359. DOI: 10.1097/pq9.0000000000000552.


Development of an Artificial Intelligence-Based Automated Recommendation System for Clinical Laboratory Tests: Retrospective Analysis of the National Health Insurance Database.

Islam M, Yang H, Poly T, Li Y JMIR Med Inform. 2020; 8(11):e24163.

PMID: 33206057 PMC: 7710445. DOI: 10.2196/24163.


Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China.

Zhang H, Song Y, Zhang X, Hu J, Yuan S, Ma J BMJ Open. 2018; 8(2):e019051.

PMID: 29490961 PMC: 5855297. DOI: 10.1136/bmjopen-2017-019051.


Effectiveness of Practices to Support Appropriate Laboratory Test Utilization: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis.

Rubinstein M, Hirsch R, Bandyopadhyay K, Madison B, Taylor T, Ranne A Am J Clin Pathol. 2018; 149(3):197-221.

PMID: 29471324 PMC: 6016712. DOI: 10.1093/ajcp/aqx147.


References
1.
Keffer J . Guidelines and algorithms: perceptions of why and when they are successful and how to improve them. Clin Chem. 2001; 47(8):1563-72. View

2.
Takemura Y, Ishida H, Inoue Y, Beck J . Common diagnostic test panels for clinical evaluation of new primary care outpatients in Japan: a cost-effectiveness evaluation. Clin Chem. 1999; 45(10):1752-61. View

3.
Takemura Y, Ishida H, Inoue Y, Beck J . Yield and cost of individual common diagnostic tests in new primary care outpatients in Japan. Clin Chem. 2001; 48(1):42-54. View

4.
Gregersen H, Ibsen J, Mellemkjoer L, Dahlerup J, Olsen J, Sorensen H . Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance. Br J Haematol. 2001; 112(2):353-7. DOI: 10.1046/j.1365-2141.2001.02533.x. View

5.
Blade J, Kyle R, Greipp P . Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Haematol. 1996; 93(2):345-51. DOI: 10.1046/j.1365-2141.1996.5191061.x. View